• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESPIRONICS, INC. TRILOGY EVO, O2, JAPAN; VENTILATOR, CONTINUOUS, FACILITY USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESPIRONICS, INC. TRILOGY EVO, O2, JAPAN; VENTILATOR, CONTINUOUS, FACILITY USE Back to Search Results
Model Number JP2100X16B
Medical Device Problem Code Circuit Failure (1089)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/17/2026
Type of Reportable Event Malfunction
Event or Problem Description
The manufacturer received information that a trilogy evo ventilator was reported to have a ventilator service required alarm.There was no patient involvement, and no harm or injury reported.On device evaluation, a ventilator service required alarm was confirmed.Device error codes e-81 and e-150 were confirmed in the device error log indicating the he oxygen proportional valve that controls the flow of oxygen to the blower inlet was mechanically stuck closed or open and oxygen flow communication ceased and the sensor is reporting the same value.Since these logged error codes regarding the oxygen blending module (obm) occurred at the same time according to the error log, it was speculated that there was a communication abnormality between the main unit and obm.The system printed circuit board assembly (pca) was replaced for the issue and it was confirmed that the issue was improved.Based on the above, it is believed that the information of from the obm could not be extracted due to a system pca malfunction, resulting in "ventilator service required" alarm occurring.After repair, the device passed final testing and confirmed to be operating properly.The software version was upgraded from 1.06.10.00 to 1.06.15.00.
 
Additional Manufacturer Narrative
The reported failure of trilogy evo ventilator communication to the oxygen blending module is accommodated in the product risk management file as being linked to hazard with description patient exposure to function / deterioration of function.Complaints for this failure are reviewed via the post market complaint trending and escalation processes to assess for the observed probability levels and compare them with the predicted levels in the risk file for the hazards linked to the failure.As of the date of submission for this report, there is no indication that complaints for the failure in question has led to unacceptable increase in probability levels for the hazardous situations in scope, and therefore no further action will be pursued.Qa continues to monitor complaints for this issue per the cadence in the complaint trending procedures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRILOGY EVO, O2, JAPAN
Common Device Name
VENTILATOR, CONTINUOUS, FACILITY USE
Manufacturer (Section D)
RESPIRONICS, INC.
1001 murry ridge lane
murrysville PA
Manufacturer (Section G)
RESPIRONICS, INC.
1001 murry ridge lane
murrysville PA
Manufacturer Contact
melissa rosko
1001 murry ridge lane
murrysville, PA 
7247330200
MDR Report Key24885132
Report Number2518422-2026-010895
Device Sequence Number9834856
Product Code CBK
UDI-Device Identifier00606959055582
UDI-Public(01)00606959055582
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K181166
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 04/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberJP2100X16B
Device Catalogue NumberJP2100X16B
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2026
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/17/2026
Initial Report FDA Received Date04/15/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/24/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-